Krsnaa Diagnostics (KRSNAA) | Stock Overview & Key Data
Krsnaa Diagnostics Performance Comparison
Stock Range
Today's Range
Low: ₹794.00
High: ₹821.60
on August 13, 2025
52 Week Range
Low: ₹625.75
High: ₹1,044.00
on May 30, 2025
on November 26, 2024
All-Time High: ₹1,099.70 on August 16, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR27.8B
EPS
23.59
P/E Ratio (TTM)
36.30
Forward P/E
21.23
P/B Ratio
3.13
PEG Ratio
21.23
Div. Yield
0.36%
ROE
9.17%
Beta
-0.149
Debt to Equity
23.06
Financial Highlights
Profitability
Gross Margin
68.32%
Operating Margin
16.68%
Profit Margin
10.82%
Returns and Earnings
Return on Assets (TTM)
5.19%
Return on Equity (TTM)
9.17%
EBITDA
INR2.2B
Net Income (TTM)
INR776.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR222.10
Quarterly Revenue Growth (YoY)
11.90%
Quarterly Earnings Growth (YoY)
10.40%
Dividend Information
Last 12-Month Dividend
₹2.50
Current Dividend Yield
0.36%
3-Year Average Dividend Yield
0.40%
3-Year Average Annual Dividend
₹2.58
3-Year Total Dividends
₹7.75
Ex-Dividend Date
September 13, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Krsnaa Diagnostics KRSNAA | 27.78B Small-cap | -4.85% | -1.95% | 8.68% | -3.30% | -11.73% | 31.73% | 87.37% | -6.46% |
| Dr. Lal PathLabs LALPATHLAB | 268.57B Large-cap | 1.93% | 12.37% | 15.99% | 21.79% | 6.65% | -2.48% | 31.33% | 74.50% |
| Syngene SYNGENE | 262.61B Large-cap | -7.00% | 1.99% | 3.73% | -8.53% | -26.19% | -22.67% | 10.06% | 33.02% |
| Vimta Labs VIMTALABS | 28.03B Small-cap | -7.61% | 35.13% | 23.92% | 7.50% | 23.08% | 144.72% | 212.02% | 1,017.54% |
| Suraksha Diagnostic SURAKSHA | 15.53B Small-cap | 1.39% | -4.19% | -0.48% | -3.93% | -21.11% | -28.84% | -28.84% | -28.84% |
| Qualitek Labs QLL | 3.02B Small-cap | 6.68% | 4.51% | 8.38% | 23.88% | -12.54% | 12.82% | 104.33% | 104.33% |
Ownership & Short Interest
Insider Ownership
43.58%
Institutional Ownership
14.58%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
61K
Average 90-Day Volume
114K
Krsnaa Diagnostics Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Krsnaa Diagnostics would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is KRSNAA's 52-week high and low?
- In the last 52 weeks, Krsnaa Diagnostics reached a high of ₹1,044.00 (on November 26, 2024) and a low of ₹625.75 (on May 30, 2025).
- What is the market cap and P/E ratio for KRSNAA?
- Curious about Krsnaa Diagnostics's size and valuation? Its market capitalization stands at 27.78B. When it comes to valuation, the P/E ratio (trailing twelve months) is 36.30, and the forward P/E (looking ahead) is 21.23.
- Does KRSNAA pay dividends? If so, what's the yield?
- Yes, Krsnaa Diagnostics is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.36%, and the company has paid an average of ₹2.58 per share annually over the past 3 years.
- Who are Krsnaa Diagnostics's main competitors or similar companies to consider before investing?
When looking at Krsnaa Diagnostics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB268.57B Healthcare Diagnostics & Research -2.48% 31.33% Syngene
SYNGENE262.61B Healthcare Diagnostics & Research -22.67% 10.06% Vimta Labs
VIMTALABS28.03B Healthcare Diagnostics & Research 144.72% 212.02% Suraksha Diagnostic
SURAKSHA15.53B Healthcare Diagnostics & Research -28.84% -28.84% Qualitek Labs
QLL3.02B Healthcare Diagnostics & Research 12.82% 104.33% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Krsnaa Diagnostics Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Krsnaa Diagnostics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.17%, the Debt to Equity ratio from the most recent quarter is 23.06, and its Gross Profit Margin stands at 68.32%.
- What is the recent revenue and earnings growth for KRSNAA?
- Looking at Krsnaa Diagnostics's growth, its revenue over the trailing twelve months (TTM) was INR7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.90%, and quarterly earnings saw a YoY growth of 10.40%.
- How much of KRSNAA stock is held by insiders and institutions?
- Wondering who owns Krsnaa Diagnostics stock? Company insiders (like executives and directors) hold about 43.58% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.58%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.